Medicines | European Medicines Agency

Medicines

For help on how to get the results you want, see our search tips.

Search results

Categories

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

PIP decision type

PIP condition / indication

Pharmaceutical form(s)

Route(s) of administration

Decision date

ATC code

Medicine type

Related medicine

Therapeutic area

Last updated

First published

2 results

Sort by

List item

Direct healthcare professional communication (DHPC): Infliximab (Remicade, Flixabi, Inflectra, Remsima and Zessly): Use of live vaccines in infants exposed in utero or during breastfeeding

Active substance: infliximab, DHPC type: New contraindication, Last updated: 07/03/2022
List item

Opinion/decision on a Paediatric investigation plan (PIP): Pelgraz, pegfilgrastim

Decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
Therapeutic area: Haematology-Hemostaseology
PIP number: EMEA-002671-PIP02-20, Route(s) of administration: Subcutaneous use, Pharmaceutical form(s): Solution for injection in pre-filled syringe
Decision date: 10/05/2021, Last updated: 11/02/2022, Compliance check: X